Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	98.77	-5.09	-414.56
Graham Fair Price	17412.47	0.43	< 0.005
PEG	100.00	< 0.005	-0.26
Price/Book	-99.86	-0.55	393.32
Price/Cash Flow	99.87	-0.30	-237.12
Prices/Earnings	99.87	-0.14	-102.49
Price/Sales	-99.76	0.18	75.26
Price/FCF	99.87	-0.30	-237.12
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	2638.64	0.10	< 0.005
Operating Margin	-84.94	-0.59	-0.32
ROA	-160.71	-0.21	-0.08
ROE	-0.96	1.01	4.79
ROIC	-0.15	-0.40	-161.16
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	< 0.005	0.01	-30.43
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.92	-0.90	53.11
EPS QOQ	-4.00	-182.80	-4470.00
FCF QOQ	-6.04	-0.93	84.64
Revenue QOQ	-0.12	0.03	-75.93
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	12.58	9.99	-20.56
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.89	1.26	41.43
Quick Ratio	0.40	0.35	-12.06
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	< 0.005	-0.09	17007.72
Cash	< 0.005	0.01	14342.45
Capex	0.00	0.00	0.00
Free Cash Flow	< 0.005	-0.17	-18576.20
Revenue	< 0.005	0.28	9856.09
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	0.49	0.40	-19.89
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-8.47	-4.55	46.25
Naive Interpretation	Member

06 - Financial Health · Bad

Rating